<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02070913</url>
  </required_header>
  <id_info>
    <org_study_id>EDC-2191</org_study_id>
    <nct_id>NCT02070913</nct_id>
  </id_info>
  <brief_title>COOL-AMI EU Case Series Clinical Study</brief_title>
  <official_title>A Single-Center Case Series Clinical Study to Assess the Feasibility of Integrating Therapeutic Hypothermia Using the ZOLL IVTM System as an Adjunctive Therapy to Percutaneous Coronary Intervention in Patients With AMI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ZOLL Circulation, Inc., USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ZOLL Circulation, Inc., USA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-center, prospective case series clinical study consecutively enrolling up to 10&#xD;
      patients with expected duration of 12 months or less. The study objectives are to evaluate&#xD;
      retention and the feasibility of integrating therapeutic hypothermia using the ZOLL IVTM&#xD;
      System.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">April 16, 2019</completion_date>
  <primary_completion_date type="Actual">April 16, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time from hospital arrival to Percutaneous Coronary Intervention (PCI).</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time from hospital arrival to initiation of cooling.</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of subjects achieving target temperature.</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of those enrolled that complete the study protocol.</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">352</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who present with clinical signs and symptoms of acute myocardial infarction and&#xD;
        meet all Inclusion and Exclusion criteria will be considered for case study presentation in&#xD;
        this clinical trial without regard to age, gender or ethnicity.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient is 18 years of age.&#xD;
&#xD;
          -  The patient must have symptoms consistent with AMI&#xD;
&#xD;
          -  MI with ST-segment elevation&#xD;
&#xD;
          -  The patient is eligible for PCI.&#xD;
&#xD;
          -  The expected timing of the treatment pathway for the patient will allow for at least&#xD;
             10 minutes of cooling with the IVTM System prior to PCI.&#xD;
&#xD;
          -  The patient or patient legal representative is willing to provide written, informed&#xD;
             consent to participate in this clinical study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The patient has had a previous myocardial infarction&#xD;
&#xD;
          -  The patient is experiencing cardiogenic shock&#xD;
&#xD;
          -  The patient is experiencing acute pulmonary edema.&#xD;
&#xD;
          -  The patient is presenting with cardiac arrest.&#xD;
&#xD;
          -  The patient is presenting with Killip risk stratification class II through IV.&#xD;
&#xD;
          -  The patient is presenting with Atrial Fibrillation.&#xD;
&#xD;
          -  The patient has a history of a prior large myocardial infarct or an infarct in the&#xD;
             same segment that is currently affected.&#xD;
&#xD;
          -  The patient requires an immediate surgical or procedural intervention other than PCI&#xD;
&#xD;
          -  The patient has an aortic dissection.&#xD;
&#xD;
          -  The patient has hepatic failure.&#xD;
&#xD;
          -  The patient has end stage kidney disease.&#xD;
&#xD;
          -  The patient is febrile&#xD;
&#xD;
          -  Known chronic Congestive Heart Failure (CHF).&#xD;
&#xD;
          -  Known previous CABG.&#xD;
&#xD;
          -  Known recent stroke&#xD;
&#xD;
          -  Cardio-pulmonary decompensation that has occurred en route to the hospital&#xD;
&#xD;
          -  Contraindications to hypothermia&#xD;
&#xD;
          -  The patient has a known hypersensitivity or contraindication to aspirin, heparin, or&#xD;
             sensitivity to contrast media, which cannot be adequately pre-medicated.&#xD;
&#xD;
          -  The patient has a known history of coagulopathy&#xD;
&#xD;
          -  The patient is known to be pregnant&#xD;
&#xD;
          -  The patient has a known hypersensitivity to antishivering medications.&#xD;
&#xD;
          -  Patient has a known history of severe hepatic or renal impairment.&#xD;
&#xD;
          -  The patient has an Inferior Vena Cava filter in place (IVC).&#xD;
&#xD;
          -  The patient has a life expectancy of less than 1 year&#xD;
&#xD;
          -  The patient has a known, unresolved history of drug use&#xD;
&#xD;
          -  The patient is currently enrolled another investigational drug or device trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Brno, Internal and Cardiology Department</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Estonia Medical Center</name>
      <address>
        <city>Tallinn</city>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ruppiner Kliniken GmbH</name>
      <address>
        <city>Neuruppin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Center Balatonfüred</name>
      <address>
        <city>Balatonfüred</city>
        <zip>8230</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gottsegen Hungarian Institute of Cardiology</name>
      <address>
        <city>Budapest</city>
        <zip>1096</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis University Heart and Vascular Center</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Centre Hungarian Defence Forces</name>
      <address>
        <city>Budapest</city>
        <zip>1134</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical and Health Science Center University of Debrecen</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miskolc Borsod-Abauj-Zemplen County Hospital and University Teaching Hospital</name>
      <address>
        <city>Miskolc</city>
        <zip>3526</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Institute University of Pecs</name>
      <address>
        <city>Pecs</city>
        <zip>7623</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szent-Györgyi Albert Clinical Centre, II (University of Szeged)</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vilnius University Hospital (Santariskiu Klinikos, Santariskiu)</name>
      <address>
        <city>Vilnius</city>
        <zip>08661</zip>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nicolaus Copernicus University, Collegium Medicum University Hospital</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-094</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology,</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Silesian Center for Heart Diseases, Zabrze</name>
      <address>
        <city>Zabrze</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University in Łódź, Bieganski Hospital</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Center of Serbia Head of Department for invasive diagnostics (Division of Cardiology)</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiovascular Diseases Vojvodina</name>
      <address>
        <city>Sremska Kamenica</city>
        <zip>21204</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Clinical Hospital Center Zemun</name>
      <address>
        <city>Zemun</city>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Sussex County Hospital</name>
      <address>
        <city>Brighton</city>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The London Barts Department of Cardiology</name>
      <address>
        <city>London</city>
        <zip>E2 9JX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Research Sister, King's College Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manchester Heart Centre Manchester Royal InfirmaryCentral Manchester University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Estonia</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Lithuania</country>
    <country>Poland</country>
    <country>Serbia</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 24, 2013</study_first_submitted>
  <study_first_submitted_qc>February 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2014</study_first_posted>
  <last_update_submitted>November 23, 2020</last_update_submitted>
  <last_update_submitted_qc>November 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypothermia</keyword>
  <keyword>Acute Myocardial Infarction</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>AMI</keyword>
  <keyword>PCI</keyword>
  <keyword>Therapeutic Hypothermia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

